Kolexia
Besson Caroline
Hématologie
Centre hospitalier de Versailles
Le Chesnay, France
189 Activités
315 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Lymphome B Lymphome malin non hodgkinien COVID-19 Hépatite C Hépatite Lymphome B diffus à grandes cellules Infections à VIH

Industries

Amgen
7 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
4 collaboration(s)
Dernière en 2022
Janssen
4 collaboration(s)
Dernière en 2023
KEPHREN PUBLISHING
4 collaboration(s)
Dernière en 2023

Dernières activités

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection   22 février 2024
EPICOVIDEHA: Epidemiology of COVID-19 Infection in Patients With Hematological Malignancies: A European Haematology Association Survey
Essai Clinique (Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne)   21 novembre 2023
(Cyclin F) as a Candidate Gene for Familial Hodgkin Lymphoma: Additional Evidence for the Importance of Mitotic Checkpoint Defects in Tumorigenesis.
HemaSphere   16 novembre 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leukemia & lymphoma   15 novembre 2023
Should the Carbon Footprint of Care be Taken into Account When Choosing a Treatment for Lymphoma? a Case Application on Mantle Cell Lymphoma
65th ASH Annual Meeting Abstracts   02 novembre 2023
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma: A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma
Essai Clinique (National Cancer Institute)   27 octobre 2023
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Blood advances   23 octobre 2023
Age, Successive Waves, Immunization, and Mortality in Elderly COVID-19 Haematological Patients: EPICOVIDEHA Findings.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases   18 octobre 2023
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
Leukemia   10 octobre 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
International journal of antimicrobial agents   13 août 2023